Alphabet portfolio — 13F holdings Q3 2026
Alphabet reported 29 long positions worth $88.3 billion as of 2026-09-30. Top holdings: SPACE EXPLORATION TECHNOLOGIES CORP, CME GROUP INC., Planet Labs PBC, ARM HOLDINGS PLC /UK, Revolution Medicines, Inc.. Quarterly changes and source links to the original SEC 13F filings. Long options are listed separately in the interactive view.
Reported share positions (up to 20)
| Company | Report period | Value | Portfolio weight | Change | Source |
|---|---|---|---|---|---|
| SPACE EXPLORATION TECHNOLOGIES CORP | 2026-09-30 | 83733871462.00 USD | 94.78% | add | Original filing |
| CME GROUP INC. | 2026-09-30 | 912743560.00 USD | 1.03% | hold | Original filing |
| Planet Labs PBC | 2026-09-30 | 577729380.00 USD | 0.65% | hold | Original filing |
| ARM HOLDINGS PLC /UK | 2026-09-30 | 567960693.00 USD | 0.64% | hold | Original filing |
| Revolution Medicines, Inc. | 2026-09-30 | 548846561.00 USD | 0.62% | reduce | Original filing |
| QUALCOMM INC/DE | 2026-09-30 | 547883767.00 USD | 0.62% | buy | Original filing |
| AST SpaceMobile, Inc. | 2026-09-30 | 526413586.00 USD | 0.60% | hold | Original filing |
| Freshworks Inc. | 2026-09-30 | 183365664.00 USD | 0.21% | reduce | Original filing |
| Parabilis Medicines, Inc. | 2026-09-30 | 158850590.00 USD | 0.18% | hold | Original filing |
| Tempus AI, Inc. | 2026-09-30 | 127035254.00 USD | 0.14% | hold | Original filing |
| UiPath, Inc. | 2026-09-30 | 90320887.00 USD | 0.10% | hold | Original filing |
| Neutron Holdings, Inc. | 2026-09-30 | 53493365.00 USD | 0.06% | buy | Original filing |
| Prime Medicine, Inc. | 2026-09-30 | 50681244.00 USD | 0.06% | hold | Original filing |
| PayPay Corp | 2026-09-30 | 49062500.00 USD | 0.06% | hold | Original filing |
| Maze Therapeutics, Inc. | 2026-09-30 | 37741686.00 USD | 0.04% | hold | Original filing |
| Freenome, Inc. | 2026-09-30 | 31848563.00 USD | 0.04% | buy | Original filing |
| Relay Therapeutics, Inc. | 2026-09-30 | 25451023.00 USD | 0.03% | hold | Original filing |
| Fervo Energy Co | 2026-09-30 | 23928354.00 USD | 0.03% | hold | Original filing |
| Ethos Technologies Inc. | 2026-09-30 | 19198918.00 USD | 0.02% | reduce | Original filing |
| OBSIDIAN THERAPEUTICS INC | 2026-09-30 | 16817451.00 USD | 0.02% | buy | Original filing |
Recent source filings (up to 20)
| Report period | Filed | Form | Source |
|---|---|---|---|
| 2026-09-30 | 2026-11-06 00:00:00 | 13F-HR | Original filing |
| 2026-06-30 | 2026-08-07 00:00:00 | 13F-HR | Original filing |
| 2026-03-31 | 2026-05-08 00:00:00 | 13F-HR | Original filing |
| 2025-12-31 | 2026-02-13 00:00:00 | 13F-HR | Original filing |
| 2025-09-30 | 2025-11-07 00:00:00 | 13F-HR | Original filing |
| 2025-06-30 | 2025-08-01 00:00:00 | 13F-HR | Original filing |
| 2025-03-31 | 2025-05-02 00:00:00 | 13F-HR | Original filing |
| 2024-12-31 | 2025-02-07 00:00:00 | 13F-HR | Original filing |
| 2024-09-30 | 2024-11-08 00:00:00 | 13F-HR | Original filing |
| 2024-06-30 | 2024-08-02 00:00:00 | 13F-HR | Original filing |
| 2024-03-31 | 2024-05-03 00:00:00 | 13F-HR | Original filing |
| 2023-12-31 | 2024-02-09 00:00:00 | 13F-HR | Original filing |
| 2023-09-30 | 2023-11-13 00:00:00 | 13F-HR | Original filing |
| 2023-06-30 | 2023-08-04 00:00:00 | 13F-HR | Original filing |
| 2023-03-31 | 2023-05-11 00:00:00 | 13F-HR | Original filing |
| 2022-12-31 | 2023-02-14 00:00:00 | 13F-HR | Original filing |
| 2022-09-30 | 2022-11-15 00:00:00 | 13F-HR | Original filing |
| 2022-06-30 | 2022-11-15 00:00:00 | 13F-HR | Original filing |
| 2022-03-31 | 2022-11-15 00:00:00 | 13F-HR | Original filing |
| 2021-12-31 | 2022-11-15 00:00:00 | 13F-HR | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.